Kodiak Sciences Inc (KOD) financial statements (2021 and earlier)

Company profile

Business Address 1200 PAGE MILL RD
PALO ALTO, CA 94304
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:9693814174303366168
Cash and cash equivalents9442922702262123745
Short-term investments251782953911252423
Other undisclosed cash, cash equivalents, and short-term investments (89)(147)(187) (0)(0)
Other undisclosed current assets312(6)302
Total current assets:9723824194253396170
Noncurrent Assets
Operating lease, right-of-use asset74762222 
Property, plant and equipment5411111
Long-term investments and receivables   912  
Long-term investments   912  
Restricted cash and investments61100000
Other noncurrent assets10987554
Other undisclosed noncurrent assets      2
Total noncurrent assets:959910182088
TOTAL ASSETS:1,0674814294433596978
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities292118131176
Accounts payable9575323
Accrued liabilities2016119953
Debt   000 
Other undisclosed current liabilities210   0
Total current liabilities:312319141276
Noncurrent Liabilities
Long-term debt and lease obligation75761122 
Operating lease, liability75761122 
Liabilities, other than long-term debt0000000
Other liabilities0000000
Other undisclosed noncurrent liabilities100100100100  2
Total noncurrent liabilities:175176101102222
Total liabilities:2071991201151498
Stockholders' equity
Stockholders' equity attributable to parent8612823093283456070
Common stock0000000
Additional paid in capital1,152526517510503202200
Accumulated other comprehensive income0010000
Accumulated deficit(291)(245)(209)(183)(158)(143)(130)
Total stockholders' equity:8612823093283456070
TOTAL LIABILITIES AND EQUITY:1,0674814294433596978

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Operating expenses(47)(37)(27)(26)(16)(13)(12)
Operating loss:(47)(37)(27)(26)(16)(13)(12)
Nonoperating income (expense)(0)111100
Investment income, nonoperating 111 00
Other nonoperating income (expense) (0)00   
Interest and debt expense(0)(0)(0)(0) (0)(0)
Loss from continuing operations before equity method investments, income taxes:(47)(36)(26)(24)(16)(12)(11)
Other undisclosed income from continuing operations before income taxes0      
Loss from continuing operations before income taxes:(47)(36)(26)(24)(16)(12)(11)
Other undisclosed loss from continuing operations(0)      
Net loss available to common stockholders, diluted:(47)(36)(26)(24)(16)(12)(11)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(47)(36)(26)(24)(16)(12)(11)
Comprehensive loss:(47)(36)(26)(24)(16)(12)(11)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)00(0)00
Comprehensive loss, net of tax, attributable to parent:(47)(36)(26)(24)(16)(12)(11)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: